{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:34:49Z","timestamp":1776720889076,"version":"3.51.2"},"reference-count":48,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/14712598.2023.2273260","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T04:38:38Z","timestamp":1697690318000},"page":"1245-1253","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Bulevirtide and emerging drugs for the treatment of hepatitis D"],"prefix":"10.1080","volume":"23","author":[{"given":"Helen Y","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Medicine, UCLA Health, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie O","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medicine, UCLA Health, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip H","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Fellow in Gastroenterology, Department of Gastroenterology, UCLA Health, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-8763","authenticated-orcid":false,"given":"Steven-Huy B","family":"Han","sequence":"additional","affiliation":[{"name":"Pfleger Liver Institute, UCLA Health, 200 Medical Plaza, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHEP.2020.04.008"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.014"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13040588"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323888"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.22965"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.011"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31055"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2017.06.002"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13040555"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401133300202"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.017"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912696"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12788"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30663-7"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix656"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13734"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1821"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2381"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.001"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.023"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01400-1"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01943-2"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)02052-9"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00318-8"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.010"},{"key":"e_1_3_4_29_1","first-page":"S294","article-title":"Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study","author":"Wedemeyer H","year":"2021","unstructured":"Wedemeyer H, Aleman S, Andreone P, et al. Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study. J Hepatol. 2021;752(Suppl):S294.","journal-title":"J Hepatol"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213429"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01953-5"},{"key":"e_1_3_4_32_1","volume-title":"Presented at The International Liver Congress","author":"Loglio","year":"2021","unstructured":"Loglio, Ferenci P, Renteria S C U, et al. Excellent virological and clinical responses maintained over 3 years of continuous bulevirtide treatment in patients with HDV compensated cirrhosis and clinically significant portal hypertension. Presented at The International Liver Congress; 2021."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01981-X"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01943-2"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16945"},{"key":"e_1_3_4_36_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03852719"},{"key":"e_1_3_4_37_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05070364"},{"key":"e_1_3_4_38_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03719313"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.025"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000309"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32259"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30288-1"},{"key":"e_1_3_4_43_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04535544"},{"key":"e_1_3_4_44_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05461170"},{"key":"e_1_3_4_45_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05674448"},{"key":"e_1_3_4_46_1","unstructured":"ClinicalTrials.gov [Internet]. (WA) (DC): U.S. National Library of Medicine; [cited 2023]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05827146"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2020.18846"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210027"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz001"},{"key":"e_1_3_4_50_1","unstructured":"Gilead Receives Complete Response Letter from U.S. FDA for bulevirtide for the treatment of adults with hepatitis delta virus [Internet]. Foster City (CA); [cited 2022]. Available from: https:\/\/www.gilead.com\/news-and-press\/company-statements\/gilead-receives-complete-response-letter-from-us-fda-for-bulevirtide-for-the-treatment-of-adults-with-hepatitis-delta-virus"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2023.2273260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T19:31:33Z","timestamp":1727206293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2023.2273260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/14712598.2023.2273260"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2023.2273260","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}